Herpes Zoster Vaccination Linked to Lower Risk for MACE, Dementia, Death
Herpes zoster vaccination is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older.
A study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek) found that vaccination against herpes zoster (HZ) reduces major adverse cardiovascular events (MACE), dementia, and all-cause mortality among older adults with HZ.
Researchers Ali Dehghani, D.O., and George Yendewa, M.D., M.P.H., from Case Western Reserve University School of Medicine in Cleveland, conducted a retrospective matched cohort study, stratifying adults aged 50 years and older with a first-time HZ diagnosis according to prior vaccination status (vaccinated or unvaccinated).
No direct quote available in the text.
Author's summary: Herpes zoster vaccination lowers heart disease risk.